{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:32:39Z","timestamp":1791268359891,"version":"4.1.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2012,3,8]],"date-time":"2012-03-08T00:00:00Z","timestamp":1331164800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s10096-012-1594-x","type":"journal-article","created":{"date-parts":[[2012,3,7]],"date-time":"2012-03-07T02:50:53Z","timestamp":1331088653000},"page":"2545-2547","source":"Crossref","is-referenced-by-count":12,"title":["The optimal aminoglycoside and its dosage for the treatment of severe Enterococcus faecalis infection. An experimental study in the rabbit endocarditis model"],"prefix":"10.1007","volume":"31","author":[{"given":"L.","family":"Dub\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Caillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Jacqueline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Bugnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Potel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Asseray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,8]]},"reference":[{"key":"1594_CR1","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehp285","volume":"30","author":"G Habib","year":"2009","unstructured":"Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, Moreillon P, de Jesus Antunes M, Thilen U, Lekakis J, Lengyel M, M\u00fcller L, Naber CK, Nihoyannopoulos P, Moritz A, Zamorano JL; ESC Committee for Practice Guidelines (2009) Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 30:2369\u20132413","journal-title":"Eur Heart J"},{"key":"1594_CR2","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1128\/AAC.44.8.2077-2080.2000","volume":"44","author":"A Lefort","year":"2000","unstructured":"Lefort A, Arthur M, Garry L, Carbon C, Courvalin P, Fantin B (2000) Bactericidal activity of gentamicin against Enterococcus faecalis in vitro and in vivo. Antimicrob Agents Chemother 44:2077\u20132080","journal-title":"Antimicrob Agents Chemother"},{"key":"1594_CR3","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1128\/AAC.27.2.224","volume":"27","author":"PM Sullam","year":"1985","unstructured":"Sullam PM, T\u00e4uber MG, Hackbarth CJ, Sande MA (1985) Antimicrobial activity of gentamicin in experimental enterococcal endocarditis. Antimicrob Agents Chemother 27:224\u2013226","journal-title":"Antimicrob Agents Chemother"},{"key":"1594_CR4","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1128\/AAC.47.11.3663-3666.2003","volume":"47","author":"L Dub\u00e9","year":"2003","unstructured":"Dub\u00e9 L, Caillon J, Gras-Le Guen C, Jacqueline C, Kergueris MF, Granry JC, Potel G, Bugnon D (2003) Simulation of human gentamicin pharmacokinetics in an experimental Enterococcus faecalis endocarditis model. Antimicrob Agents Chemother 47:3663\u20133666","journal-title":"Antimicrob Agents Chemother"},{"key":"1594_CR5","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/jac\/dkl044","volume":"57","author":"ME Falagas","year":"2006","unstructured":"Falagas ME, Matthaiou DK, Bliziotis IA (2006) The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials. J Antimicrob Chemother 57:639\u2013647","journal-title":"J Antimicrob Chemother"},{"key":"1594_CR6","unstructured":"Comit\u00e9 de l\u2019Antibiogramme de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie. Recommandations 2009. http:\/\/www.sfm-microbiologie.org\/UserFiles\/file\/CASFM\/casfm_2009-1.pdf"},{"key":"1594_CR7","first-page":"206","volume":"44","author":"BB Perlman","year":"1971","unstructured":"Perlman BB, Freedman LR (1971) Experimental endocarditis. II. Staphylococcal infection of the aortic valve following placement of a polyethylene catheter in the left side of the heart. Yale J Bio Med 44:206\u2013213","journal-title":"Yale J Bio Med"},{"key":"1594_CR8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1006\/bulm.1997.0013","volume":"60","author":"D Bugnon","year":"1998","unstructured":"Bugnon D, Potel G, Caillon J, Baron D, Drugeon HB, Feigel P, Kergueris MF (1998) In vivo simulation of human pharmacokinetics in the rabbit. Bull Math Biol 60:545\u2013567","journal-title":"Bull Math Biol"},{"key":"1594_CR9","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1128\/AAC.46.5.1591-1593.2002","volume":"46","author":"N Asseray","year":"2002","unstructured":"Asseray N, Caillon J, Roux N, Jacqueline C, Bismuth R, Kergueris MF, Potel G, Bugnon D (2002) Different aminoglycoside-resistant phenotypes in a rabbit Staphylococcus aureus endocarditis infection model. Antimicrob Agents Chemother 46:1591\u20131593","journal-title":"Antimicrob Agents Chemother"},{"key":"1594_CR10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1128\/AAC.40.1.173","volume":"40","author":"J Gavald\u00e0","year":"1996","unstructured":"Gavald\u00e0 J, Cardona PJ, Almirante B, Capdevila JA, Laguarda M, Pou L, Crespo E, Pigrau C, Pahissa A (1996) Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum. Antimicrob Agents Chemother 40:173\u2013178","journal-title":"Antimicrob Agents Chemother"},{"key":"1594_CR11","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/jac\/dkg360","volume":"52","author":"J Gavald\u00e1","year":"2003","unstructured":"Gavald\u00e1 J, Onrubia PL, G\u00f3mez MT, Gomis X, Ram\u00edrez JL, Len O, Rodr\u00edguez D, Crespo M, Ru\u00edz I, Pahissa A (2003) Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides. J Antimicrob Chemother 52:514\u2013517","journal-title":"J Antimicrob Chemother"},{"key":"1594_CR12","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1128\/AAC.45.5.1387-1393.2001","volume":"45","author":"P L\u00f3pez","year":"2001","unstructured":"L\u00f3pez P, Gavald\u00e0 J, Martin MT, Almirante B, Gomis X, Azuaje C, Borrell N, Pou L, Falc\u00f3 V, Pigrau C, Pahissa A (2001) Efficacy of teicoplanin\u2013gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditis. Antimicrob Agents Chemother 45:1387\u20131393","journal-title":"Antimicrob Agents Chemother"},{"key":"1594_CR13","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/00003246-199705000-00016","volume":"25","author":"G Lugo","year":"1997","unstructured":"Lugo G, Casta\u00f1eda-Hern\u00e1ndez G (1997) Relationship between hemodynamic and vital support measures and pharmacokinetic variability of amikacin in critically ill patients with sepsis. Crit Care Med 25:806\u2013811","journal-title":"Crit Care Med"},{"key":"1594_CR14","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s00134-002-1313-7","volume":"28","author":"SE Buijk","year":"2002","unstructured":"Buijk SE, Mouton JW, Gyssens IC, Verbrugh HA, Bruining HA (2002) Experience with a once-daily dosing program of aminoglycosides in critically ill patients. Intensive Care Med 28:936\u2013942","journal-title":"Intensive Care Med"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-012-1594-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-012-1594-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-012-1594-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T01:24:36Z","timestamp":1561425876000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-012-1594-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,8]]},"references-count":14,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["1594"],"URL":"https:\/\/doi.org\/10.1007\/s10096-012-1594-x","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,8]]}}}